Researchers Validate Technology and Mouse Model for ID’ing Protein Cancer Markers | GenomeWeb
A multi-institutional team of researchers has used genetically engineered mouse models to validate a method to quantitatively analyze proteins in the plasma proteome at the picomolar and even sub-picomolar level, according to a recent paper.
The goal of their research is to identify potential disease biomarkers, therefore addressing a major bottleneck in protein biomarker research.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.